Pharmaceutical company YURiA-PHARM was found in  1998. Today YURiA-PHARM is the leader manufacturer of  solutions for infusion not only in Ukraine but also in CIS. We supply medical facilities with more than 100 items of bloodand plasma substitute solutions, original infusion drugs, antibiotics, fungicidal drugs, syrups, antiseptics, parenteral feeding preparations, anti-tuberculosis drugs, syringes, I.V. sets. The assortment of products fully covers the requirements of stationary curative establishments in infusion therapy. Our product line sums up to more than 40 preparations. Annual turnover of the company exceeds 60 mln bottles per year.

We deliver our products to Russia, Moldova, Kazakhstan, Uzbekistan, Azerbaijan, Tajikistan, Kirgizia, Turkmenistan and Georgia. More than 100 items are now being registered for usage in different countries and the number is continuously growing. In 2008 YURiA-PHARM Corporation has received a Certificate of compliance to international quality management standards ISO 9001 (9001:2009). In 2011 YURiA-PHARM Corporation has complited WHO-GMP certification. Now we plan to enter Asia- Pacific, African and South America markets, therefore in some countries we have already started the registration process for the preparations planned to be distributed. YURiA-PHARM total headcount is constantly growing and at the moment exceeds 800, 2/3 of them being involved in production and R&D.

Our company produces a number of preparations (original and generic), which are not produces in CIS countries - Reosorbilact®, Sorbilact®, Decasan®, Horosten® etc. For instance, Reosorbilact® (30% of total distribution of the preparations included in B 05 ATC code (B05 - Blood substitutes and perfusion solutions) and Sorbilact® constitute a basis of infusion therapy in Ukraine. They have completely replaced polyvinylpyrrolidone preparations (such as Hemodez, Neohemodez etc.) prohibited in many European and other countries, and restricted dextran preparations (Reopolyglucin). In our portfolio we also have unique cosmetological treatments - Hyalual® (an anti-age therapy, preparation for realization of procedure of redermalization - rejuvenations by renewal), injectional preparations modifying a cartilage - Hyalual®-Artro - unique innovative cartilage protective preparation of new generation. It is an effective combination of hyaluronic acid and sodium succinate, which already has showed the efficiency in treatment of patients with osteoarthrosis.

We cooperate intensively with many research institutions in the field. For the first time in CIS, in collaboration with Blood Pathology and Transfusion Medicine Institute of Ukraine's Academy of Medical Science, we have developed a group of complex multifunctional infusion solutions - Reosorbilact®, Sorbilact®, Xylat®, which today make basis of new direction in the clinic of internal medicine - "Low-volume infusion therapy". Corporation conduct an intensive research of the new preparations and also examine more deeply the capacity of the existing ones. We make large investments in Research & Development and prove the quality and efficiency of our preparation according to the requirements of the “case-based medicine”.

Keeping in mind constant enhancing of quality and accessibility of treatment, we improve the presentations and dosages of the preparations on a permanent basis. At the moment our products are released in 9 forms, including prefilled syringes, nebules, bags for irrigation solutions, polypropylene bags, PVC bags, glass bottles, plastic bottles, tablets.

Our preparations accelerate the patients' recovery due to their higher efficiency, considerable decrease of complications and minimization of side-effects. Numerous reputable medical investigations prove a visible time saving in stationary treatment and higher therapy comfort level. These factors allow reducing the treatment cost and increasing an average annual bed turnover.

«YURiA-PHARM» - a reliable and advantageous partner

According to YURiA-PHARM long experience, practical usage of its preparations enhances an overall image both of a medical facility and of the physician. Uncompromising quality and reasonable pricing have made our preparations bestsellers in Ukraine and CIS and we have every reason to expect similar success in other countries.

«YURiA-PHARM» - some short facts:

• leader in production of solutions for infusion;
• annually growth rate more than 40%;
• more than 100 items in the product line;
• total headcount more than 800;
• annual turnover up to 60 million units;
• exports to 9 countries;
• 80% of annual net profit is invested in modernization of
production;
• each year about 10 new medical preparations are delivered;
• system quality control ISO 9001 : 2009 operates;
• GMP certified.